A first-in-human phase I study of SAR125844, a selective MET tyrosine kinase inhibitor, in patients with advanced solid tumours with MET amplification
| Image |  |
|---|---|
| Description | scientific article published on 13 November 2017 |
| Author/s |
author: Eric Angevin |
| Publication date | November 13, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |